Simcere Zaiming, Inc.
SEC Form 4 insider trading activity
Simcere Zaiming, Inc. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 12, 2026.
On the most recent filing, Simcere Zaiming, Inc. is listed as Insider at NextCure, Inc. Inside the rolling window, Simcere Zaiming, Inc. reported no open-market purchases and 1 open-market sale totaling $185K in NXTC.
Companies traded
Other insiders at NXTC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$185K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Simcere Zaiming, Inc. made?
Simcere Zaiming, Inc. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Simcere Zaiming, Inc. trade?
Simcere Zaiming, Inc. has filed SEC Form 4 disclosures for 1 company, including NXTC.
When was Simcere Zaiming, Inc.'s most recent SEC Form 4 filing?
Simcere Zaiming, Inc.'s most recent SEC Form 4 filing on Tracefour is dated Aug 12, 2026.
What is Simcere Zaiming, Inc.'s total buy and sell value in the current window?
Inside the rolling retention window, Simcere Zaiming, Inc. bought $0 and sold $185K based on SEC Form 4 filings.
What was Simcere Zaiming, Inc.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,000 NXTC shares on 2026-08-10, worth $185K, per SEC Form 4 filings.